Major Growth Driver Identified in 2025 Candida Infection Testing Market: Rising Yeast Infection Rates Drive Growth In Candida Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Candida Infection Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for testing candida infections has witnessed a robust growth in recent years. It is projected to expand from $15.69 billion in 2024 to $16.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.6%. Reasons that led to the growth in the past include a surge in candida infections, heightened awareness and diagnostic measures, enhanced healthcare infrastructure, an increase in hospital-related infections, and additional funding for research.

Candida Infection Testing Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, the market size of candida infection testing is predicted to experience robust expansion. It is predicted that by 2029 it will escalate to $21.29 billion, with a compound annual growth rate (CAGR) of 6.2%. The surge during the forecast period could be due to the advent of new candida strains, increased consciousness regarding fungal infections, broadened healthcare accessibility, the aging populace, and rising awareness as well as preventive healthcare. Significant trends during the forecast period encompass advancements in molecular diagnostics, the incorporation of digital health technologies, AI integration, machine learning integration, and tailoring of medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report

What Are the Drivers Transforming the Candida Infection Testing Market?
The growth of the candida infection testing market is projected to accelerate due to the rising prevalence of yeast infections. Yeast infections are fungal afflictions brought about by an excess proliferation of candida, typically impacting regions like the skin, mouth, and genitals, and are often accompanied by symptoms such as itching, redness, and general discomfort. They are mainly triggered by an overabundance of the candida fungus, frequently due to an imbalance in the body's natural bacteria, weakened immunity systems, or hormonal shifts. Testing for a candida infection is routinely conducted during yeast infections to confidently diagnose an excess growth of candida, aiding healthcare practitioners in confirming the infection and directing suitable treatment. For example, data from GOV.UK, a government agency in the UK, revealed that in 2022, the prevalence of bloodstream infections (BSI) attributed to yeast in England stood at 4.0 per 100,000 individuals, indicating a 4% rise from 2021. Hence, the escalating occurrence of yeast infections is expected to underpin the expansion of the candida infection testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp

What Long-Term Trends Will Define the Future of the Candida Infection Testing Market?
Key players in the candida infection testing market are striving to introduce technologically advanced solutions, like the fully automated Polymerase Chain Reaction (PCR) quick test for detecting candida, with an aim to increase diagnostic precision and enhance patient care. The said test is a sophisticated diagnostic tool that utilizes PCR technology to rapidly and accurately detect the presence of Candida strains in clinical samples. For example, in May 2024, a PCR test for recognizing candida auris was launched by Bosch Healthcare Solutions GmbH, a medical technology firm based in Germany, on their Vivalytic platform. This fully automated, quick test provides results within an hour at the point of treatment, a major leap from traditional culture techniques which take one to three days in centralized labs and therefore, postpone the diagnosis and treatment. Tailor-made for clinical surroundings, this test is highly beneficial for patients at high risk, facilitating swift diagnosis and treatment, thereby mitigating the grave health issues related to C. auris infections.

Which Segments in the Candida Infection Testing Market Offer the Most Profit Potential?
The candida infection testingmarket covered in this report is segmented -

1) By Type: Invasive Candidiasis, Candidemia
2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test
3) By Application: Hospital, Laboratory

Subsegments:
1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing
2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19356&type=smp

Which Firms Dominate the Candida Infection Testing Market by Market Share and Revenue in 2025?
Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC

Which Regions Offer the Highest Growth Potential in the Candida Infection Testing Market?
North America was the largest region in the candida infection testing market in 2024. The regions covered in the candida infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19356

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.